Transparency data

Meeting minutes of the Vaccine Benefit Risk Expert Working Group from the Covid-19 Pandemic - 3 December 2021 to 29 March 2022

Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 3 December 2021 and 29 March 2022.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 19 December 2024

Documents

3 December 2021

PDF, 219 KB, 9 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

10 December 2021

PDF, 234 KB, 13 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

6 January 2022

PDF, 195 KB, 6 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

13 January 2022

PDF, 215 KB, 9 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

19 January 2022

PDF, 184 KB, 7 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

4 February 2022

PDF, 232 KB, 10 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

18 February 2022

PDF, 218 KB, 11 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

4 March 2022

PDF, 64.7 KB, 8 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

18 March 2022

PDF, 240 KB, 11 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

29 March 2022

PDF, 224 KB, 9 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

As part of our ongoing mission to improve transparency, we are publishing minutes taken from meetings of the Commission on Human Medicines’ Vaccine Benefit Risk Expert Working Group (VBREWG) between 25 August 2020 and 5 May 2023. The VBREWG meetings focused on evaluating the safety, efficacy, and overall benefits versus risks of vaccines, providing expert advice and recommendations on licensing and regulatory action.  

Under Section 40 and 43 of the Freedom of Information Act respectively, personal data of individuals and commercially sensitive information has been redacted from these minutes.

Published 19 December 2024